Typically, BCP‐ALL in affected family members exhibits secondary somatic aberrations involving the wild‐type PAX5 allele, including structural variants or loss of heterozygosity (LOH) of chromosome 9p, as well as PAX5 somatic mutations. Here, PAX5 is linked to acute lymphoblastic leukemia.